2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

Welcome to the latest of our Eberhard F. Mammen award announcements. As noted many times previously, Thieme, the publisher of Seminars in Thrombosis and Hemostasis (STH), has created the “ Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards ” in honor of Eberhard Mammen ([ Fig. 1 ]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades (see [ Table 1 ] for relevant references). These awards began in 2009 under two categories; the current award details and conditions are as follows: Table 1 Listing of relevant editorials published in STH as related to the initiation of the Eberhard F. Mammen awards, as well as previous award announcements 1. Favaloro EJ. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008. Semin Thromb Hemost 2008;34(8):693–696 2. Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008;34(8):703–708 3. Favaloro EJ. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009;35(1):1–2 4. Favaloro EJ. Winners of the inaugural Eberhard F. Mammen Award for Most Popular Article. Semin Thromb Hemost 2009;35(7):587–590 5. Favaloro EJ. 2009 Eberhard F. Mammen Young Investigator Award Winners. Semin Thromb Hemost 2010;36(5):469–470 6. Favaloro EJ. Winners of the 2010 Eberhard F. Mammen Award for Most Popular Article during 2008-2009. Semin Thromb Hemost 2010;36(7):685-692 7. Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011;37(5):431-439 8. Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012; 38(5):425-432 9. Favaloro EJ. 2013 Eberhard F. Mammen award announcements. Semin Thromb Hemost 39(6):567–574 10. Favaloro EJ. 2014 Eberhard F. Mammen award announcements: Part I - Most popular articles. Semin Thromb Hemost 2014;40(4):407–412 11. Favaloro EJ. 2014 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2014;40(7):718–723 12. Favaloro EJ. 2015 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2015;41(7):673–679 13. Favaloro EJ. 2015 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2015;41(8):809–815 14. Favaloro EJ. 2016 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2016;42(4):325-330 15. Favaloro EJ. 2016 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2017;43(3):235-241 16. Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2017;43(4):357–363 17. Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2018;44(2):81–88 18. Favaloro EJ. 2018 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2018;44(3):185–192 19. Favaloro EJ. 2018 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2019;45(2):123–129 20. Favaloro EJ. 2019 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2019;45(3):215–224 21. Favaloro EJ. 2019 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2020;46(2):105–113 22. Favaloro EJ. 2020 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2020;46(4):383–392 23. Favaloro EJ. 2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2021;47(3):229–237 24. Favaloro EJ. 2021 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2021;47(5):467–476 25. Favaloro EJ. 2021 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2022;48(3):265–273 26. Favaloro EJ. 2022 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2022;48(5):502–513 27. Favaloro EJ. 2023 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2023;49(5):417-426 Fig. 1 Eberhard F. Mammen (1930-2008). Most popular article awards : Awarded to the authors of the most popular articles published in STH in the preceding 2 years as captured in the preceding year. The awards are determined by the editor in chief on the basis of user statistics from Thieme e-Journals. Prefaces, Errata, Letters to the Editor, Editorials, Commentaries, and previous award-winning articles are excluded from further consideration of these awards, which currently comprise two categories—one for “Free Access” articles and another for a “General Category.” There are two major cash prizes of U.S. $1,000 for each category. In addition, winners of the “General Category” awards are granted “Free Access” status for these articles thereafter. Young investigator awards : Best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen (up to six cash prizes of U.S. $1,000 in any year). There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in STH . In general, previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the senior editors of STH. Any potential conflicts of interest are managed by first identifying these, and then excluding those with potential conflicts from voting. Finally, given the ongoing COVID-19 pandemic, many international congresses have become virtual meetings, and accordingly, virtual meeting presentations can also be considered for the award. Further details of the awards and the award winners are posted online ( https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ), and previous award winner announcements are also available in print (see [ Table 1 ] for a listing of relevant editorials published in this journal as related to the initiation of the Eberhard F. Mammen awards, as well as previous award announcements); these publications are also available for free download from the journal website: https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 . The winners of the 2022 Eberhard F. Mammen awards for the most popular articles from STH for the period of 2020–2021 inclusive were announced in an earlier issue of the journal,[ 1 ] as were the 2023 Eberhard F. Mammen awards for the most popular articles from STH for the period of 2021–2022 inclusive.[ 2 ] It is therefore with great pleasure that we would like to announce the winners of the latest round of Young Investigator awards. As mentioned earlier, the Young Investigator Awards represent winners of the best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting (virtual meetings permissible) on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. There are additional considerations, given that the nominees' presentations are not necessarily seen by all of the possible award nominators, being drawn from the broader editorial team of the journal as well as potentially from outside the editorial team, nor necessarily seen by all the voting team (comprising the senior editors of the journal). The latest winners are identified later, with a running list of previous awardees, and the resulting publications in the journal, given in [ Table 2 ]. The latest awardees derived from recent meetings of the International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA). Table 2 Eberhard F. Mammen Young Investigator Award winners from previous years Awardee Year awarded Publication arising Willem M. Lijfering 2009 Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost 2011;37(8):885–896 Salley Pels 2009 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost 2011;37(6):621–30 Adam Cuker 2010 Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia. Semin Thromb Hemost 2012;38(1):31–37 Giridhara Rao Jayandharan 2010 Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost 2012;38(1):64–78 Timea Szanto 2010 Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost 2012;38(1):55–63 Birgitta Salmela 2010 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost 2012;38(1):23–30 Pia Riittaa-Maria Siljander 2010 Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 2012;38(1):102–113 Romaric Lacroix 2011 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 2013;39(1):33–39 Brad McEwen 2011 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 2013;39(1):25–32 Neil A. Goldenberg 2011 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research. Semin Thromb Hemost 2013;39(1):10–14 Vivien Chen 2011 Chen VM. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin Thromb Hemost 2013;39(1):40–47 Joseph E. Italiano Jr. 2011 Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb Hemost 2013;39(1):15–24 Vivian Xiaoyan Du 2012/2013 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014;40(1):72–80 Andrew Yee 2012/2013 Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost. 2014;40(1):17–27 Sarah O'Brien 2012/2013 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb Hemost 2014;40(1):66–71 Veronica Flood 2012/2013 Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand disease. Semin Thromb Hemost 2014;40(1):41–48 Julie Tange 2012/2013 Tange JI, Grill D, Koch CD, Ybabez RJ, Krekelberg BJ, Fylling KA, Wiese CR, Baumann NA, Block DR, Karon BS, Chen D, Pruthi RK. Local verification and assignment of mean normal prothrombin time and international sensitivity index values across various instruments: recent experience and outcome from North America. Semin Thromb Hemost 2014;40(1):115–120 Kent Chapman 2012/2013 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present, and future. Semin Thromb Hemost 2014;40(1):34–40 Andreas Tiede 2014 Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia a: limitations, consequences, and challenges. Semin Thromb Hemost 2014;40(7):803–811 Wendy Lim 2014 Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost 2014;40(7):741–746 Susana Nobre Fernandes 2014 Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis approach on young adults with severe hemophilia. Semin Thromb Hemost 2014;40(7):785–789 Maria Elisa Mancuso 2014 Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool during by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb Hemost 2016;42(1):30–35 Coen Maas 2014 Tersteeg C, Fijnheer R, Deforche L, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C. Keeping von Willebrand factor under control: Alternatives for ADAMTS13. Semin Thromb Hemost 2016;42(1):9–17 Riten Kumar 2014 Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life factor concentrates and gene therapy. Semin Thromb Hemost 2016;42(1):18–29 Juraj Sokol 2015 Sokol J, Skerenova M, Jedinakova Z, Simurda T, Skornova I, Stasko J, Kubisz P. Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 2017;43(1):8–13 Ljubica Jovanović 2015 Jovanovic L, Antonijevic N, Novakovic T, Savic N, Terzic B, Zivkovic I, Radovanovic N, Asanin M. Practical aspects of monitoring of antiplatelet therapy. Semin Thromb Hemost 2017;43(1):14–23 Lucia Stanciakova 2015 Stanciakova L, Dobrotova M, Jedinakova Z, Duraj L, Skornova I, Korinkova L, Holly P, Danko J, Stasko J, Kubisz P. Monitoring of hemostasis and management of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal loss. Semin Thromb Hemost 2016;42(6):612–621 Tina Biss 2015 Biss TT. Venous thromboembolism in children: Is it preventable? Semin Thromb Hemost 2016;42(6):603–611 Tobias Fuchs 2015 Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis? Semin Thromb Hemost 2017;43(6):553–561 Jonathan M. Coutinho 2015 Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for cerebral venous thrombosis. Semin Thromb Hemost 2016;42(6):622–631 Soundarya Selvam 2016 Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost 2017;43(6):572–580 Vincent Muczynski 2016 Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging therapeutic strategies in the treatment of hemophilia A. Semin Thromb Hemost 2017;43(6):581–590 Karen Schreiber 2016 Schreiber K, Breen K, Cohen H, Jacobsen S, Middeldorp S, Pavord S, Regan L, Roccatello D, Robinson SE, Sciascia S, Seed PT, Watkins L, Hunt BJ. HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies. Semin Thromb Hemost 2017;43(6):562–571 Jasmine Wee Ting Tay 2016 Tay J, Tiao J, Hughes Q, Jorritsma J, Gilmore G, Baker R. Circulating microRNA as thrombosis sentinels: caveats and considerations. Semin Thromb Hemost 2018;44(3):206–215 Adi J. Klil-Drori 2016 Klil-Drori AJ, Tagalakis V. Direct oral anticoagulants in end-stage renal disease. Semin Thromb Hemost 2018;44(4):353–363 Ivar van Asten 2017 van Asten I, Schutgens REG, Urbanus RT. Toward flow cytometry based platelet function diagnostics. Semin Thromb Hemost 2018;44(3):197–205 Elodie Laridan 2017 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2017 R, J, thrombotic purpura: a review of diagnosis and treatment in Semin Thromb Hemost 2017 Favaloro J. or oral anticoagulants to bleeding risk a review of and Semin Thromb Hemost 2018 M, for the factor mechanisms of current and emerging Semin Thromb Hemost James 2018 H, as in an role and a new Semin Thromb Hemost 2018 The current role of platelet function in clinical Semin Thromb Hemost 2018 J, Sokol J, Simurda T, L, Z, D, Dobrotova M, J, Skornova I, Z, Kubisz P, Stasko J. of von Willebrand disease: current and Semin Thromb Hemost 2018 T, M, I, P, J, Kubisz P, M. and on bleeding and Semin Thromb Hemost 2018 The role of in and Semin Thromb Hemost Elisa 2019 E, M, M, The role of in the of Semin Thromb Hemost Ward 2019 Ward S, The of von Willebrand Semin Thromb Hemost Jonathan 2019 J, L, C. and venous on that enable and assessment of the Semin Thromb Hemost 2019 and to for Semin Thromb Hemost 2019 B, K, M. Current in the management of women with von Willebrand disease. Semin Thromb Hemost 2019 D, Rosendaal and the risk of venous thrombosis. Semin Thromb Hemost 2020 therapies for bleeding in a for Semin Thromb Hemost 2020 C, T, E, J, I, M, S, N, L, K, G, S, P, L, C, R, J, A, P, Venous thromboembolism in patients COVID-19 Semin Thromb Hemost 2020 2020 Effects of on hemostasis in patients with disease. Semin Thromb Hemost 2020 Maria 2020 Favaloro Chen VM. of thrombosis in heparin-induced thrombocytopenia and immune thrombotic thrombocytopenia. Semin Thromb Hemost 2021 The from to to in to COVID-19 patients and in clinical Semin Thromb Hemost 2021 2021 B. 2021 and are not the clinical of Semin Thromb Hemost 2021 S. in and Impact on Tissue Semin Thromb Hemost. 2023 18. 2021 As with these awards, the current of winners a of various of their awardees are on their in or are in their and over into the of their be ([ Fig. 2 is the of our award and is currently the of Thrombosis and Hemostasis and the in the by and on the between and this from both a and is in to become a clinical and is a of the Society for Thrombosis and Hemostasis Fig. 2 Young Investigator Award winner ([ Fig. is another of the in 2021 in the of of and the of in under the of Dr. on for the role of in hemostasis and identified a role for in function. currently as a in the immune can function. award based on an oral presented the meeting Is for Fig. Young Investigator Award winner ([ Fig. is the of our is a and and of on understanding the of and to both the and in is to with antiplatelet a therapeutic approach to the of disease. Fig. Young Investigator Award winner ([ Fig. is an in the of on the role of coagulation factors in and have published in in the fields of thrombosis and hemostasis, and Dr. is also to for by the as a of the and as the to the Fig. Young Investigator Award winner ([ Fig. is of the young investigator and in clinical in and from and of is in and and also a of American of In as a in cardiovascular and then to a in an role in on thrombotic and published in and two in the of and a review on in Thromb Fig. Young Investigator Award winner ([ Fig. is another of the young investigator currently as a laboratory the Haemostasis and Thrombosis of of in has for over years in the field of hemostasis and thrombosis. a in and of hemostasis and thrombosis a in clinical has the on factor and von Willebrand In recent he has to more the of coagulation he is the regional for the Society for the of Haemostasis and Thrombosis Fig. Young Investigator Award winner award winners were to that selected to an Eberhard F. Mammen Young Investigator award, and the additional I and to be awarded an Eberhard F. Mammen Young Investigator would not be possible the and contribution of many in I would like to Dr. Cannegieter and Dr. for their and A special to Dr. our presented on thrombosis and for this award. a to the editorial of Seminars in Thrombosis and Hemostasis for this award to as a more in the field of thrombosis and hemostasis and I to on this ([ Fig. 2 I to be of the of the 2022 Eberhard F. Mammen Young Investigator It is a to have and I would like to the editorial of Seminars in Thrombosis and Haemostasis for this of this would have possible the of I would like to for his and I would also like to to all our and in the for whose has I to on to to further our understanding of ([ Fig. I to have and selected for an Eberhard F. Mammen Young Investigator the of previous and their it is to have our in a and to the our on the between and the it is and to that in thrombosis our presentation this is possible by a team and I to for award the in as I to into an ([ Fig. It is a honor to be selected for of the 2022 Eberhard F. Mammen Young Investigator Awards. I would like to to the Seminars in Thrombosis and Hemostasis editorial for their recognition of in would not have possible the of Dr. James the of our and our from the of I to have the current and previous winners of this award, all of are young in thrombosis and ([ Fig. I to have selected for a 2022 Eberhard F. Mammen Young Investigator I to and Dr. for all his and I would also like to to another for his to and Finally, I to the and the Seminars in Thrombosis and Hemostasis editorial team for the recognition awarded to award have an on as I to of an investigator in the field of thrombosis. ([ Fig. I and to be awarded a 2022 Eberhard F. Mammen Young Investigator award our on the that factors I this from the with a an in the field of I also to recognition to the team this I would like to De for his for his and for the time to Finally, I would like to Favaloro and the editorial of Seminars in Thrombosis and Hemostasis for as based on oral the 2022 for this ([ Fig. In with previous I have the Young Investigator from previous years as well as the outcome of their to STH as in [ Table 2 ]. The most recent arising publications are also in the list for the of the ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] I have mentioned times that most of the from earlier years have in further some of these or the young have of the Most Popular awards (see [ Table 1 ] for a list of editorials on these the by a previous Young Investigator ] a winner in the 2023 Most Popular as 2 ] I to to the of the current and Young Investigator winners over are for Young Investigator and I all awardees the best of to the by earlier award Publication Article published 2023 Thieme New